Rationing healthcare in South Africa: Renal replacement therapy – a case in point.
نویسندگان
چکیده
593 September 2014, Vol. 104, No. 9 Rationing healthcare in South Africa: Renal replacement therapy – a case in point To the Editor: The South African Dialysis and Transplant Registry issued its last report on renal replacement therapy (RRT) in South Africa (SA) in 1994, followed by an unfortunate hiatus for 20 years. The recent publication of the long-awaited South African Renal Registry Annual Report 2012 should be highly commended.[1] The private sector deserves to be acknowledged for its financial support of this initiative. Since 1994, the SA population has increased from 40.436 million to 52.275 million and the treatment rate for end-stage renal disease (ESRD) per million population (pmp) has improved from 70 pmp in 1994 to 164 pmp in 2012.[1] The treatment rate in 2012 for the public sector is essentially unchanged at 73 pmp, compared with 620 pmp (of insured persons) in the private sector. In contrast, the low national kidney transplant rate of 4.7 pmp highlights the dire need for organs.[1] Between 1994 and 2012, the number of public sector treatment centres offering dialysis increased from 26 to 28, while in the private sector there was an increase from 5 to 163.[1] There has been a population-appropriate change in the relative representation of different ethnic groups, with a 64% increase in black patients accessing RRT since 1994 and a drop of 50% in white patients. There are still two provinces in SA – Limpopo and Mpumalanga – with no public dialysis facility. The annual increase in people requiring RRT worldwide is estimated to be 8%, which is far in excess of the global population growth rate of 1.3%.[2] In the light of a large chronic disease burden in SA, contributed to by both communicable and non-communicable diseases, with chronic kidney disease arising largely from diabetes, hypertension, obesity and HIV,[3] an increase in RRT services beyond 8% is required. In 2006, Professor M R Moosa of Tygerberg Academic Hospital (TAH), Cape Town, stated: ‘In 1997, the funding of our dialysis unit was capped to allow treatment of 80 patients with [ESRD] and has remained unchanged since.’[4] He showed that 52% of ESRD patients are denied RRT treatment at TAH.[4] Despite ongoing rationing without review and the subsequent denial of treatment, there is very little public awareness and debate around the rationing process and policy that regulates patient access to RRT. There is also no independent body that reviews the medical ethics of rationing in the public sector (which is often centre-specific). Kidney transplant rates remain low. In 2012, there were no kidney transplants performed in public sector centres in either Free State or KwaZulu-Natal provinces. In Gauteng and the Western Cape, 22 and 21 kidney transplants, respectively, were performed at public sector transplant units. Of the 110 adult cadaveric kidney transplants done in 2012, 43 (39.1%) were in the public sector. The discrepancy between private and public sector transplant rates and regional differences in transplant activity highlight the complexity around organ procurement, organ allocation and transplantation in different regions, which is a separate, complex debate. In the light of the registry data, the government needs to be made aware of these figures for planning and service provision in the public sector. The Minister of Health, Dr Aaron Motsoaledi, has met with Prof. Razeen Davids, first author of the South African Renal Registry Annual Report 2012,[1] to discuss the data. He has constructively suggested a summit later this year to discuss chronic/ ESRD management strategies. June Fabian Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, and Research Unit, Wits Donald Gordon Medical Centre, Johannesburg [email protected]
منابع مشابه
Renal histopathological and biochemical changes following adjuvant intervention of Momordica charantia and antiretroviral therapy in diabetic rats
Objective(s): Diabetic nephropathy (DN) is an important primary cause of end-stage kidney disease. This study explores the mechanisms of the reno-protective effects of Momordica charantia (M. charantia) in diabetic rats following treatment with highly active antiretroviral therapy (HAART) regimen triplavar. Materials and Methods: Adult m...
متن کاملChallenges in Expanding Access to Dialysis in South Africa—Expensive Modalities, Cost Constraints and Human Rights
South Africa is a country with two distinct health sectors, which are both characterised by inequalities. Within this context, patients with end stage renal disease face unique and sometimes impenetrable barriers to accessing dialysis. There are a number of reasons for this situation. These include: the South African government's endorsement of discordant, unequal policies, which disadvantage t...
متن کاملFinancing for Healthcare in Sub-Saharan Africa and South Asia: Risk Pooling & Risk-Sharing Arrangements; Essential Strategy for Overcoming Poverty Costs
متن کامل
The Purview of Phytotherapy in the Management of Kidney Disorders: a Systematic Review on Nigeria and South Africa
BACKGROUND The kidney is tasked with a number of metabolic functions in the body. In its role as a detoxifier and primary eliminator of xenobiotics, it becomes vulnerable to developing injuries. Currently, over 1 million people in the world are living on renal replacement therapies (RRTs). The case in sub-Sahara African countries like Nigeria and South Africa is not any better than the global t...
متن کاملDifferences and inequalities in relation to access to renal replacement therapy in the BRICS countries.
End-stage renal disease (ESRD) is an important public health problem, especially in developing countries due to the high level of economic resources needed to maintain patients in the different programs that make up renal replacement therapy (RRT). To analyze the differences and inequalities involved in access to RRT in the BRICS countries (Brazil, Russian Federation, India, China and South Afr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
دوره 104 9 شماره
صفحات -
تاریخ انتشار 2014